We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $7.06B
1-Year Est. Return 3.43%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$15B
AUM Growth
+$883M
Cap. Flow
-$645M
Cap. Flow %
-4.3%
Top 10 Hldgs %
44.85%
Holding
26
New
1
Increased
1
Reduced
23
Closed
1

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$567M
2
DG icon
Dollar General
DG
+$66.8M

Sector Composition

Rank Sector Weight
1 Financials 31.68%
2 Healthcare 23.29%
3 Technology 20.95%
4 Consumer Staples 9.73%
5 Consumer Discretionary 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHX icon
26
L3Harris
LHX
$55.4B
-1,524,007
Closed -$265M

Similar funds

Longview Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Longview Partners held 26 positions worth $15B, up 6.3% from $14.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Longview Partners withdrew a net $645M in Q4 2023, closing 1 position and reducing 23 holdings. Its most notable exit was L3Harris, an estimated $265M position sold in full.

By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Longview Partners opened a new position in Thermo Fisher Scientific worth $622M.

  • Longview Partners's largest Q4 2023 buy was Thermo Fisher Scientific: 1,171,709 shares worth $622M.
  • Longview Partners added most to Dollar General in Q4 2023, an estimated $66.8M increase.
  • Longview Partners's biggest Q4 2023 reduction was Bank of New York Mellon, cutting an estimated $68.4M.
  • Longview Partners fully exited L3Harris in Q4 2023, selling an estimated $265M.
  • Longview Partners's ten largest holdings make up 45% of its $15B portfolio in Q4 2023.
  • Longview Partners opened 1 new position and closed 1 in Q4 2023.
  • Longview Partners's portfolio value rose 6.3% quarter-over-quarter to $15B.

Based on Longview Partners's 13F filing for Q4 2023, filed 13 Feb 2024.